University of California San Francisco

Georg Wieselthaler, MD
Georg
Wieselthaler
MD

Emeritus Professor of Surgery
Division of Cardiothoracic Surgery

UCSF Diversity, Equity, and Inclusion Champion badge

Address

500 Parnassus Avenue, #W424
San Francisco, CA 94117
United States

Email: [email protected]
Phone: 415-353-8196
Fax: 415-353-1312

    Biography

    Dr. Georg Wieselthaler, a heart and lung surgeon, is director of the Heart Transplant Program and Mechanical Circulatory Support Program at the UCSF Heart & Vascular Center. He is one of the world's leading experts in mechanical circulatory support for patients with end-stage heart failure and has performed and supervised more than 350 heart transplants. He also has extensive expertise in implanting ventricular assist devices (VADs), which help failing hearts pump blood.

    Wieselthaler, a native of Austria, earned a medical degree at the University of Vienna, where he completed a residency and surgical training. He also completed advanced training in transplantation at the Vienna heart transplant and lung transplant programs.

    Wieselthaler has been involved in the development of ventricular assist pumps and a total artificial heart. He has trained surgeons worldwide in implantation techniques and the use of VADs, and he has published numerous articles in peer-reviewed journals.

    Wieselthaler is a member of many national and international medical societies. He is president-elect of the International Society for Rotary Blood Pumps. He is on the board of the European Society for Artificial Organs and former president of the Austrian Society for Implantology and Tissue Integrated Prosthesis. In April 2011, he was named director of the International Society for Heart and Lung Transplantation.

    Read a Q&A with Wieselthaler.

    Education

    Institution Degree Dept or School End Date
    University of California Diversity, Equity, and Inclusion Champion Training 2018
    University of Vienna M.D. School of Medicine 1987

    Clinical Expertise

    Acute Aortic Dissection Repair
    Aortic Valve Repair & Replacement
    Off-Pump Coronary Artery Bypass (OBCAB)
    Coronary Artery Bypass Grafting (CABG)
    End Stage Heart Failure
    Heart Transplantation
    Minimally Invasive Cardiac Surgery
    Minimally Invasive Valve Surgery
    Mitral Valve Repair & Replacement
    Myocardial Revascularization Surgery
    Thoracic Aneurysm Repair
    Thoracic Aortic Reconstruction
    Ventricular Aneurysm
    Ventricular Assist Devices (VAD)
    Arrhythmia

    Program Affiliations

    UCSF Heart & Vascular Center

    In the News

    February, 01, 2013 | UCSF Adult Cardiothoracic Surgery

    Research Narrative

    In 1984, while still in medical school, Dr. Wieselthaler became involved in the Ventricular Assist Device (VAD) Program  at the University of Vienna  and began working in the Biomedical Laboratory on the development of the driving unit for the "New Vienna Total Artificial Heart (TAH)". After graduation, Dr. Wieselthaler became aware of the advantages of rotary blood pumps and organized the world´s the first "International Workshop(s) on Rotary Blood Pumps" in the years 1988 and 1991 in Austria. Out of these meetings, the International Society for Rotary Blood Pumps was founded in 1992 with Dr. Wieselthaler acting as Secretary General for the organization for many years.

    Dr. Wieselthaler and colleague Dr. Heinrich Schima, a biomedical engineer, then investigated and developed miniaturized centrifugal pumps over15 years in the Biomedical Laboratories of the University of Vienna. Dr. Wieselthaler thereafter became primary surgeon at the Medical University of Vienna where implanted various types of VAD systems and supervised patient care. He developed extensive expertise with pulsatile systems like Novacor LVAS and has had one of the longest supported patients on the device (over 4 1/2  years). He also developed the Thoratec paracorporeal and implantable VADs. One of his patients was supported more than 3 years on the world´s first full implantable VAD in the Arrow LionHeart CUPS Trial.

    In 1998, Dr. Wieselthaler implanted the world's first implantable, miniaturized axial flow pumps, the MicroMed-DeBakey VAD and he has since implanted more than 80 patients with this device. Many of Dr. Wieselthaler´s leading scientific papers originated his early experience with the world´s first nonpulsatile pump, articles still cited by colleagues. Dr. Wieselthaler also served as  Principal Investigator and implanted the world´s first implantable, magnetically suspended centrifugal left ventricular assist device (LVAD), the "TERUMO DuraHeart LVAD".

    In 2003, Dr. Wieselthaler joined a HeartWare Inc, Miramar, FL as a consultant and over the next three years, played a key role in the development the HeartWare HVAD, a miniaturized hydromagnatically levitated centrifugal pump. and in 2006, he implanted the world's first patients with this system.

    Dr. Wieselthaler continued working with HeartWare on the next generation LVAD, known as the "Miniaturised Ventricular Assist Device (MVAD)", leading to two patent applications in his name for the technology: 1) a minimally invasive implantation technique of the MVAD, and 2) a special shaped inflow cannula tip for the MVAD.

    Research Interests

    Ventricular Assist Devices (VAD)

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 106
    1. Intraoperative identification and treatment of a giant right coronary artery aneurysm.
      Ramirez J, Wieselthaler G, Kratz J| | PubMed
    2. Response by Andreas et al to Letter Regarding Article, "Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial".
      Andreas M, Moayedifar R, Wieselthaler G, Wolzt M, Riebandt J, Haberl T, Angleitner P, Schlöglhofer T, Wiedemann D, Schima H, Laufer G, Zimpfer D| | PubMed
    3. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection.
      Kusne S, Mooney M, Danziger-Isakov L, Kaan A, Lund LH, Lyster H, Wieselthaler G, Aslam S, Cagliostro B, Chen J, Combs P, Cochrane A, Conway J, Cowger J, Frigerio M, Gellatly R, Grossi P, Gustafsson F, Hannan M, Lorts A, Martin S, Pinney S, Silveira FP, Schubert S, Schueler S, Strueber M, Uriel N, Wrightson N, Zabner R, Huprikar S| | PubMed
    4. Increased Thromboembolic Events With Dabigatran Compared With Vitamin K Antagonism in Left Ventricular Assist Device Patients: A Randomized Controlled Pilot Trial.
      Andreas M, Moayedifar R, Wieselthaler G, Wolzt M, Riebandt J, Haberl T, Angleitner P, Schlöglhofer T, Wiedemann D, Schima H, Laufer G, Zimpfer D| | PubMed
    5. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review.
      Baumann Kreuziger LM, Kim B, Wieselthaler GM| | PubMed
    6. Ventricular assist devices for treatment of acute heart failure and chronic heart failure.
      Kirkpatrick JN, Wieselthaler G, Strueber M, St John Sutton MG, Rame JE| | PubMed
    7. Welcome to ISRBP 2014.
      Wieselthaler GM, Slaughter M| | PubMed
    8. Lack of donor and recipient age interaction in cardiac transplantation.
      Eskandary FA, Kohl M, Dunkler D, Aliabadi A, Grömmer M, Schiferer A, Gökler J, Wieselthaler G, Laufer G, Zuckermann A| | PubMed
    9. Results of the post-market Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE).
      Strueber M, Larbalestier R, Jansz P, Zimpfer D, Fiane AE, Tsui S, Simon A, Schmitto JD, Khaghani A, Wieselthaler GM, Najarian K, Schueler S| | PubMed
    10. Extended in vivo evaluation of a miniaturized axial flow pump with a novel inflow cannula for a minimal invasive implantation procedure.
      Schima H, Zrunek P, Stoiber M, Larose J, Shambaugh C, Tamez D, Deckert Z, Plasenzotti R, Bergmeister H, Wieselthaler G| | PubMed